Nobilis Therapeutics’ NBTX-001 shows promise in treatment of patients with Panic Disorder
14. Juni 2017 13:34 ET
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 14, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, Inc. announced today that the results of the clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in...
Behavioral Health Pioneer Palo Alto Health Sciences, Inc. Strengthens Executive Team with New Chief Clinical Officer and Vice President of Business Development
15. September 2016 11:00 ET
|
Palo Alto Health Sciences, Inc.
DANVILLE, Calif., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Palo Alto Health Sciences (PAHS), maker of the Freespira Breathing System®, is excited to welcome Dr. Robert Cuyler as Chief Clinical Officer...